Stokes Frank's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Nov 19, 2024
- Accession no.
- 0001447362-24-000187
- Filed
- Nov 19, 2024
- Trade date
- Nov 15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $207.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stokes FrankCIK 0001782815 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Common Stock | SSaleDisposed | −6,123 | $29.87 | −$182,894.01 | 31,623 | Direct | |
| Nov 15, 2024 | Common Stock | SSaleDisposed | −800 | $30.40 | −$24,320 | 30,823 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.